Related references
Note: Only part of the references are listed.Clinical Pharmacokinetics of Fingolimod
Olivier J. David et al.
CLINICAL PHARMACOKINETICS (2012)
Mechanisms of Fingolimod's Efficacy and Adverse Effects in Multiple Sclerosis
Jeffrey A. Cohen et al.
ANNALS OF NEUROLOGY (2011)
Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis
David Henrique Rodrigues et al.
BRAIN RESEARCH (2011)
ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Zahra Tanfin et al.
CELLULAR SIGNALLING (2011)
Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier
Xueqian Wang et al.
FASEB JOURNAL (2011)
Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS
Xueqian Wang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Oral treatment for multiple sclerosis
Joep Killestein et al.
LANCET NEUROLOGY (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The outs and the ins of sphingosine-1-phosphate in immunity
Sarah Spiegel et al.
NATURE REVIEWS IMMUNOLOGY (2011)
T lymphocytes impair P-glycoprotein function during neuroinflammation
Gijs Kooij et al.
JOURNAL OF AUTOIMMUNITY (2010)
Activation of PKC isoform βI at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
Robert R. Rigor et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity
Anika M. S. Hartz et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay
Brian T. Hawkins et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Rapid, Reversible Modulation of Blood-Brain Barrier P-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
Brian T. Hawkins et al.
JOURNAL OF NEUROSCIENCE (2010)
Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier
Xueqian Wang et al.
MOLECULAR PHARMACOLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain
Ayman ElAli et al.
SCIENCE SIGNALING (2010)
Targeting the Sphingolipid Signaling Pathway in Stroke
Waltraud Pfeilschifter et al.
STROKE (2010)
Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier
David S. Miller
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation
Gijs Kooij et al.
PLOS ONE (2009)
Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier
Anika M. S. Hartz et al.
FASEB JOURNAL (2008)
Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTπ, at the blood-brain barrier
Bjoern Bauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling
Bjoern Bauer et al.
MOLECULAR PHARMACOLOGY (2008)
A genomic comparison of in vivo and in vitro brain microvascular endothelial cells
Anthony R. Calabria et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2007)
Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells
Anthony Pilorget et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Role of ABCO in export of sphingosine-1-phosphate from mast cells
Poulami Mitra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2006)
Multidrug transporters as drug targets
X. -J. Liang et al.
CURRENT DRUG TARGETS (2006)
Rapid modulation of p-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-α and lipopolysaccharide
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2006)
Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors - A novel pathway relevant to the pathophysiology of endothelium
C De Palma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2004)
Impact of drug transporter studies on drug discovery and development
N Mizuno et al.
PHARMACOLOGICAL REVIEWS (2003)
FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes
SM Honig et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
S Fellner et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor
RJ Raggers et al.
BIOCHEMICAL JOURNAL (2001)
Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds
C Dagenais et al.
PHARMACEUTICAL RESEARCH (2001)
Share Paper
